This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Ashland (ASH) Earnings & Sales Fall Short of Estimates in Q4
by Zacks Equity Research
Ashland (ASH) faced challenges from softer industrial end-market demand and weak results at Pharmachem and Personal Care businesses in Q4.
Ashland (ASH) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of -21.43% and -5.12%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Ashland (ASH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland (ASH) Earnings Expected to Grow: What to Know Ahead of Q4 Release
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland (ASH) Q3 Earnings Meet Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 0.00% and 0.19%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for July 24th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Analysts Estimate Ashland (ASH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for May 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for May 24th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Earnings Preview: Ashland (ASH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland to Hike Price of Composites Products in North America
by Zacks Equity Research
Per Ashland (ASH), the hike is mainly driven by persistent increase in cost of key raw materials, freight and tariffs.
Ashland (ASH) to Hike Composites Products Prices in EMEA
by Zacks Equity Research
Ashland's (ASH) move is in response to the persistent increase in cost of key raw materials.
Ashland (ASH) Beats Q1 Earnings, Misses Revenue Estimates
by Zacks Equity Research
Ashland's (ASH) Specialty Ingredients unit gains from improved product mix and pricing in Q1, partly offset by unfavorable currency. The company reaffirms previously announced outlook.
Ashland (ASH) Beats Q1 Earnings Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 27.27% and -2.33%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Ashland (ASH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland (ASH) Inks New Composites Distribution Agreement
by Zacks Equity Research
Ashland's (ASH) latest move to boost growth in Sweden, Norway and Denmark.
3 Chemical Stocks to Enrich Your Portfolio Before Q4 Earnings
by Anindya Barman
We have shortlisted three chemical stocks that are worth investing in before the Q4 earnings season hits full throttle.
Ashland (ASH) Raises Prices of Composites Products in India
by Zacks Equity Research
Ashland (ASH) decides to raise prices due to increase in costs of raw materials.
Ashland (ASH) Releases Update on Fiscal 2019 Financial View
by Zacks Equity Research
Ashland (ASH) projects adjusted EPS for fiscal 2019 in the range of $3.10-$3.40, reflecting the pending divestiture of the Composites unit and the BDO manufacturing facility.
Ashland (ASH) Wraps Up HEC Expansion, Boosts Production
by Zacks Equity Research
Capacity expansion enables Ashland (ASH) to support increasing demand for Natrosol HEC.
Ashland (ASH) Up 15% in a Year: What's Working in Favor?
by Anindya Barman
Strategic initiatives have contributed to the gain in Ashland's (ASH) shares.
Here's Why Ingevity (NGVT) Stock is Worth Buying Right Now
by Anindya Barman
Let's see what makes Ingevity (NGVT) stock an attractive investment option at the moment.
US Specialty Chemicals Volumes Up in October: 3 Stocks to Buy
by Anindya Barman
While specialty chemical companies face headwinds from trade tensions and raw material inflation, they should gain from healthy end-market demand and strategic initiatives.
Why Should You Add Air Products (APD) to Your Portfolio?
by Anindya Barman
Air Products (APD) seems to be an attractive choice for investment based on its underlying strength and upbeat prospects.